Log In
Print
BCIQ
Print
Print this Print this
 

NKTR-181

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionOral mu opioid receptor (OPRM1; MOR) agonist
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat moderate to severe chronic pain; Treat osteoarthitis (OA) knee pain
Regulatory Designation

U.S. - Fast Track (Treat chronic pain)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today